Android app Apple app link

Kura Oncology, Inc. (KURA) and Kyowa Kirin to Present Promising Ziftomenib Data at ASCO 2025

By Yahoo! Finance   |   1 month ago
Kura Oncology, Inc. (KURA) and Kyowa Kirin to Present Promising Ziftomenib Data at ASCO 2025

Kura Oncology and Kyowa Kirin will present full data from the KOMET-001 trial on ziftomenib at the 2025 ASCO Annual Meeting.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.